Interestingly, novel data provided further insights on FAK and AKT correlation (67): in a preclinical model of ovarian cancer, the protein tyrosine phosphatase non-receptor type 12 (PTPN12) dephosphorylates FAK, shutting down the migratory properties. The gene discussed is PTK2; the disease is ovarian cancer.